Tetanus and botulinum neurotoxins: Turning bad guys into good by research

Toxicon

Volumn 39, Issue 1, 2001, Pages 27-41

  Rossetto, Ornella ^a   Seveso, Michela ^a   Caccin, Paola ^a   Schiavo, Giampietro ^b   Montecucco, Cesare ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN C; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; METALLOPROTEINASE; NERVE PROTEIN; NEUROTOXIN; SYNAPTOBREVIN; SYNAPTOSOME ASSOCIATED PROTEIN; TETANUS TOXIN; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ARTICLE; BOTULISM; CHOLINERGIC SYNAPSE; CLINICAL TRIAL; CLOSTRIDIUM; DRUG BINDING; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG TRANSPORT; ENZYME ACTIVITY; EXOCYTOSIS; HUMAN; INTERNEURON; NEUROTOXICITY; NEUROTOXICOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; TETANUS; TORTICOLLIS; TOXIN STRUCTURE;

CLOSTRIDIUM;

EID: 0035239239     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(00)00163-X     Document Type: Short Survey

References (168)

1. Angaut-Petit D., Molgo J., Comella J.X., Faille L., Tabti N. Terminal sprouting in mouse neuromuscular junctions poisoned with botulinum type A toxin: morphological and electrophysiological features. Neuroscience. 37:1990;799-808.
2. Bakry N., Kamata Y., Sorensen R., Simson L.L. Tetanus toxin and neuronal membranes: the relationship between binding and neurotoxicity. J. Pharmacol. Exp. Ther. 258:1991;613-619.
3. 2+ dependent exocytosis. J. Biol. Chem. 271:1996;20227-20230.
4. 2+-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J. Biol. Chem. 269:1994;8122-8127.
5. Beise J., Hahnen J., Andersen-Beckh B., Dreyer F. Pore formation by tetanus toxin, its chain and fragments in neuronal membranes and evaluation of the underlying motifs in the structure of the toxin molecule. Naunyn Schemiedebergs Arch. Pharmacol. 349:1994;66-73.
6. Bernard, C., 1866. Leçons sur le propriétés des tissus vivants. Paris.
7. Binz T., Blasi J., Yamasaki S., Baumeister A., Link E., Sudhof T.C., Jahn R., Niemann H. Proteolysis of SNAP-25 by types E and A botulinal neurotoxins. J. Biol. Chem. 269:1994;1617-1620.
8. 125I -labeled botulinum neurotoxins with nerve terminals. Part II: Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J. Cell Biol. 103:1986;535-544.
9. Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., De Camilli P., Sudhof T.C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature. 365:1993;160-163.
10. Blasi J., Chapman E.R., Yamasaki S., Binz T., Niemann H., Jahn R. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J. 12:1993;4821-4828.
11. Blaustein R.O., Germann W.J., Finkelstein A., DasGupta B.R. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett. 226:1987;115-120.
12. Brooks V.B., Curtis D.R., Eccles J.C. Mode of action of tetanus toxin. Nature. 175:1955;120-121.
13. Bock J.B., Scheller R.H. SNARE proteins mediate lipid bilayer fusion. Proc. Natl. Acad. Sci. USA. 96:1999;12227-12229.
14. Borodic G.E., Ferrante R.J., Perace L.B., Alderson K. Pharmacology and histology of the therapeutic application of botulinum toxin. Jankovic J., Hallett M. Therapy with Botulinum Toxin. 1994;119-157 Marcel Dekker, New York.
15. Boquet P., Duflot E. Tetanus toxin fragment forms channels in lipid vesicles at low pH. Proc. Natl. Acad. Sci. USA. 79:1982;7614-7618.
16. Burgen A.S.V., Dickens F., Zatman L.J. The action of botulinum toxin on the neuromuscular junction. J. Phisiol. (Lond.). 109:1949;10-24.
17. Cabiaux V., Lorge P., Vandenbranden M., Falmagne P., Ruysschaert J.M. Tetanus toxin induces fusion and aggregation of lipid vesicles containing phosphatidylinositol at low pH. Biochem. Biophys. Res. Commun. 128:1985;840-849.
18. Carle A., Rattone G. Studio sperimentale sull'eziologia del tetano. Giorn. Accad. Med. Torino. 32:1884;174-179.
19. 2+ and drives membrane fusion. Cell. 97:1999;165-174.
20. Coen L., Osta R., Maury M., Brulet P. Construction of hybrid proteins that migrate retrogradely and transsynaptically into the central nervous system. Proc. Natl. Acad. Sci. USA. 94:1997;9400-9405.
21. Coffield J.A., Bakry N.M., Maksymowych A.B., Simpson L.L. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin. J. Pharmacol. Exp. Ther. 289:1999;1509-1516.
22. Comella J.X., Molgo J., Faille L. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions. Neurosci. Lett. 153:1993;61-64.
23. Cornille F., Goudreau N., Ficheux D., Niemann H., Roques B.P. Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain. Eur. J. Biochem. 222:1994;173-181.
24. Cornille F., Deloye F., Fournie-Zaluski M.C., Roques B.P., Poulain B. Inhibition of neurotransmitter release by synthetic proline-rich peptides shows that the N-terminal domain of vesicle-associated membrane protein/synaptobrevin is critical for neuroexocytosis. J. Biol. Chem. 270:1995;16826-16832.
25. Cornille F., Martin L., Lenoir C., Cussac D., Roques B.P., Fournie-Zaluski M.C. Cooperative exosite-dependent cleavage of synaptobrevin by tetanus toxin light-chain. J. Biol. Chem. 272:1997;3459-3464.
26. Cremona O., De Camilli P. Synaptic vesicle endocytosis. Curr. Opin. Neurol. 7:1997;323-330.
27. Criado M., Gil A., Viniegra S., Gutierrez L.M. A single amino acid near the C terminus of the synaptosome associated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells. Proc. Natl. Acad. Sci. USA. 96:1999;7256-7261.
28. Critchley D.R., Nelson P.G., Habig W.H., Fishman P.H. Fate of tetanus toxin bound to the surface of primary neurons in culture: evidence for rapid internalization. J. Cell. Biol. 100:1985;1499-1507.
29. Das Gupta B.R. Structures of botulinum neurotoxin, its functional domains, and perspectives on the cristalline type A toxin. Jankovic J., Hallett M. Therapy with Botulinum Toxin. 1994;15-39 Marcel Dekker, New York.
30. De Filippis V., Vangelista L., Schiavo G., Tonello F., Montecucco C. Structural studies on the zinc-endopeptidase light chain of tetanus neurotoxin. Eur. J. Biochem. 229:1995;61-69.
31. de Paiva A., Ashton A.C., Foran P., Schiavo G., Montecucco C., Dolly J.O. Botulinum A like type B and tetanus toxins fulfils criteria for being a zinc-dependent protease. J. Neurochem. 61:1993;2338-2341.
32. de Paiva A., Meunier F.A., Molgo J., Aoki K.R., Dolly J.O. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parents terminals. Proc. Natl. Acad. Sci. USA. 96:1999;3200-3205.
33. Dolly J.O., Black J., Williams R.S., Melling J. Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization. Nature. 307:1984;457-460.
34. Eisel U., Reynolds K., Riddick M., Zimmer A., Niemann H., Zimmer A. Tetanus toxin light chain expression in Sertoli cells of transgenic mice causes alterations of the actin cytoskeleton and disrupts spermatogenesis. EMBO. J. 12:1993;3365-3372.
35. Eleopra R., Tugnoli V., Rossetto O., Montecucco C., De Grandis D. Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci. Lett. 224:1997;91-94.
36. Eleopra R., Tugnoli V., Rossetto O., De Grandis D., Montecucco C. Botulinum neurotoxin serotype A and E in human: evidence of a different temporal profile in the neuromuscular block induced. Neurosci. Lett. 224:1998;91-94.
37. Faber K. Die Pathogenie des Tetanus. Berl. klin. Wochenschr. 27:1890;717-720.
38. Ferrier Montiel A.V., Gutierrez L.M., Apland J.P., Canaves J.M., Gil A., Viniegra S., Biser J.A., Adler M., Montal M. The 26-mer peptide released from SNAP-25 cleavage by botulinum neurotoxin E inhibits vesicle docking. FEBS Lett. 435:1998;84-88.
39. Foran P., Shone C.C., Dolly J.O. Differences in the protease activities of tetanus and botulinum B toxins revealed by the cleavage of vesicle-associated membrane protein and various sized fragments. Biochemistry. 33:1994;15365-15374.
40. Foran P., Lawrence G.W., Shone C.C., Foster K.A., Dolly J.O. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release. Biochemistry. 35:1996;2630-2636.
41. Francis J.W., Hosler B.A., Brown H.R. Jr, Fishman P.S. CuZn superoxide dismutase (SOD-1): tetanus toxin fragment C hybrid protein for targeted delivery of SOD-1 to neuronal cells. J. Bio. Chem. 270:1995;15434-15442.
42. Galazka A., Gasse F. The present status of tetanus and tetanus vaccination. Curr. Top. Microbiol. Immunol. 195:1995;31-53.
43. Gambale F., Montal M. Characterization of the channel properties of tetanus toxin in planar lipid bilayers. Biophys. J. 53:1988;771-783.
44. 2+-dependent binding of synaptotagmin to SNARE complexes. J. Biol. Chem. 275:2000;6328-6336.
45. Gutierrez L.M., Viniegra S., Rueda J., Ferrier Montiel A.V., Canaves J.M., Montal M. A peptide that mimics the C-terminal sequence of SNAP-25 inhibits secretory vesicle docking in chromaffin cells. J. Biol. Chem. 272:1997;2634-2639.
46. Habermann E., Dreyer F., Bigalke H. Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schemiedebergs. Arch. Pharmacol. 311:1980;33-40.
47. Habermann E., Dreyer F. Clostridial neurotoxins: handling and action at the cellular and molecular level. Curr. Top. Microbiol. Immunol. 129:1986;93-179.
48. Habig W.H., Bigalke H., Bergey G.K., Neale E.A., Hardegree M.C., Nelson P.G. Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action. J. Neurochem. 47:1986;930-937.
49. Halpern J.L., Loftus A. Characterization of the receptor-binding domain of tetanus toxin. J. Biol. Chem. 268:1993;11188-11192.
50. Halpern J.L., Neale E.A. Neurospecific binding, internalization, and retrograde axonal transport. Curr. Top. Microbiol. Immunol. 195:1995;221-241.
51. Hayashi T., McMahon H., Yamasaki S., Binz T., Hata Y., Sudhof T.C., Niemann H. Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J. 13:1994;5051-5061.
52. Herreros J., Marti E., Ruiz-Montasell B., Casanova A., Niemann H., Blasi J. Localization of putative receptors for tetanus toxin and botulinum neurotoxin type A in rat central nervous system. Eur. J. Neurosci. 9:1997;2677-2686.
53. Herreros, J., Lalli, G., Schiavo, G., 2000. C-terminal half of tetanus toxin fragment C is sufficient for neuronal binding and interaction with a putative protein receptor. Biochem. J. 347, 199-204.
54. Hoch D.H., Romero-Mira M., Ehrlich B.E., Finkelstein A., Das gupta B.R., Simpson L.L. Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes. Proc. Natl. Acad. Sci. USA. 82:1985;1692-1696.
55. Hohne-Zell B., Ecker A., Weller U., Gratzl M. Synaptobrevin cleavage by the tetanus toxin light chain is linked to the inhibition of exocytosis in chromaffin cells. FEBS Lett. 355:1994;131-134.
56. Hua S.Y., Charlton M. Activity dependent changes in partial-VAMP complexes during neurotransmitter release. Nature Neurosci. 2:1999;1078-1083.
57. Hughes R., Whaler B.C. Influence of nerve-endings activity and of drugs on the rate of paralysis of rat diaphragm preparations by Clostridium botulinum type A toxin. J. Physiol. (Lond.). 160:1962;221-233.
58. Hunt J.M., Bommert K., Charlton M.P., Kistner A., Habermann E., Augustine G.J., Betz H. A post-docking role for synaptobrevin in synaptic vesicle fusion. Neuron. 12:1994;1269-1279.
59. Jankovic J., Hallett M. Therapy with Botulinum Toxin. 1994;Marcel Dekker, New York.
60. Kauffman J.A., Way J.F. Jr, Siegel L.S., Sellin L.C. Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction. Toxicol. Appl. Pharmacol. 79:1985;211-217.
61. Keller J.E., Neale E.A., Oyler G., Adler M. Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett. 456:1999;137-142.
62. Kryzhanovsky G.N. Central nervous changes in experimental tetanus and the mode of action of the tetanus toxin. Communication I: Irradiation of the excitation on stimulating the tetanized limb. Bull. Exp. Biol. Med. 44:1958;1456-1464.
63. Kurazono H., Mochida S., Binz T., Eisel U., Quanz M., Grebenstein O., Wernars K., Poulain B., Tauc L., Niemann H. Minimal essential domains specifying toxicity of the light chains of tetanus toxin and botulinum neurotoxin type A. J. Biol. Chem. 267:1992;14721-14729.
64. Lacy B.D., Tepp W., Das Gupta B.R., Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nature Struct. Biology. 5:1998;898-902.
65. Lacy B.D., Stevens R.C. Crystal structure of botulinum neurotoxin type A and implications for toxicity. J. Mol. Biol. 291:1999;1091-1104.
66. Lalli G., Herreros J., Osborne S.L., Montecucco C., Rossetto O., Schiavo G. Functional characterization of tetanus and botulinum neurotoxins binding domains. J. Cell. Sci. 112:1999;2715-2724.
67. Lang J., Regazzi R., Wollheim C.B. Clostridial toxins and endocrine secretion: their use in insuline secreting cells. Aktories K. Bacterial Toxins. Tools in Cell Biology and Pharmacology. 1997;217-237 Chapman and Hall, London.
68. Lawrence G.W., Foran P., Mohammed N., Das gupta B.R., Dolly J.O. Importance of two adjacent C-terminal sequences of SNAP-25 in exocytosis from intact and permeabilized chromaffin cells revealed by inhibition with botulinum neurotoxins A and E. Biochemistry. 36:1997;3061-3067.
69. Lebeda F.J., Olson M.A. Structural predictions of the channel-forming region of botulinum neurotoxin heavy chain. Toxicon. 33:1995;559-567.
70. Li L., Binz T., Niemann H., Singh B.R. Probing the mechanistic role of glutamate residue in the zinc binding motif of type A botulinum neurotoxin light chain. Biochemistry. 39:2000;2399-2405.
71. Ludlow C.L., Hallett M., Rhew K., Cole R., Shimizu T., Sakaguchi G., Bagley J.A., Schulz G.M., Yin S.G., Koda J. Therapeutic use of type F botulinum toxin. N. Engl. J. Med. 326:1992;349-350.
72. Lundh H., Leander S., Thesleff S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J. Neurol. Sci. 32:1977;29-43.
73. Marsal J., Ruiz-Montasell B., Blasi J., Moreira J.E., Contreras D., Sugimori M., Llinas R. Block of transmission release by botulinum C1 action on syntaxin at the squid giant synapse. Proc. Natl. Acad. Sci. USA. 94:1997;14871-14876.
74. Martoglio B., Hofmann M.W., Brunner J., Dobberstein B. The protein-conducting channel in the membrane of the endoplasmic reticulum is open laterally toward the lipid bilayer. Cell 1995. 81:1995;207-214.
75. Marxen P., Bigalke H. The chromaffin cell: a suitable model for investigating the actions and the metabolism of tetanus and botulinum A neurotoxin. Naunyn Schemiedebergs Arch. Pharmacol. 343:1991;12-29.
76. Matteoli M., Verderio C., Rossetto O., Iezzi N., Coco S., Schiavo G., Montecucco C. Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc. Natl. Acad. Sci. USA. 93:1996;13310-13315.
77. Mellanby J., Beaumont M.A., Thompson P.A. The effect of lanthanum on nerve terminals in goldfish muscle after paralysis with tetanus toxin. Neuroscience. 25:1988;1095-1106.
78. Menestrina G., Forti S., Gambale F. Interaction of tetanus toxin with lipid vesicles. Effects of pH, surface charge, and transmembrane potential on the kinetics of channel formation. Biophys. J. 55:1989;393-405.
79. Minton N.P. Molecular genetics of clostridial neurotoxins. Curr. Top. Microbiol. Immunol. 195:1995;161-194.
80. Molgo J., Das gupta B.R., Thesleff S. Characterization of the actions of botulinum neurotoxin type E at the rat neuromuscular junction. Acta. Physiol. Scan. 137:1989;497-501.
81. Montecucco C. How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem. Sci. 11:1986;315-317.
82. Montecucco C., Schiavo G., Brunner J., Duflot E., Boquet P., Roa M. Tetanus toxin is labeled with photoactivatable phospholipids at low pH. Biochemistry. 25:1986;919-924.
83. Montecucco C., Schiavo G., Das gupta B.R. Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes. Biochem. J. 259:1989;47-53.
84. Montecucco C., Papini E., Schiavo G. Molecular models of toxin membrane translocation. Alouf J.E., Freer J.H. A Sourcebook of Bacterial Protein Toxins. 1991;Academic Press, London.
85. Montecucco C., Schiavo G. Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends Biochem. Sci. 18:1993;324-327.
86. Montecucco C., Papini E., Schiavo G. Bacterial protein toxins penetrate cells via a four-step mechanism. FEBS Lett. 346:1994;92-98.
87. Morante S., Furenlid L., Schiavo G., Tonello F., Zwilling R., Montecucco C. X-ray absorption spectroscopy study of zinc coordination in tetanus neurotoxin, astacin, alkaline protease and thermolysin. Eur. J. Biochem. 235:1996;606-612.
88. Naumann M., Jost W.H., Toyka K.V. Botulinum toxin in the treatment of neurological disorders of the autonomic nervous system. Arch. Neurol. 56:1999;914-916.
89. Neale E.A., Habig W.H., Schrier B.K., Bergey G.K., Bowers L.M., Koh J. Application of tetanus toxin for structure-function studies in neuronal cell cultures. Nistico' G., Bizzini B., Bytchencko B., Triau R. Eight International Conference on Tetanus. 1989;66-70 Pythagora Press, Rome.
90. Neale E.A., Bowers L.M., Jia M., Bateman K.E., Williamson L.C. Botulinum neurotoxin A blocks synaptic vesicle exocytosis but not endocytosis at the nerve terminal. J. Cell. Biol. 147:1999;1249-1260.
91. Niemann H. Molecular biology of clostridial neurotoxins. Alouf J.E., Freer J.J. A Sourcebook of Bacterial Protein Toxins. 1991;303-348 Academic Press, London.
92. Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sato K., Sekiguchi M., Takahashi M., Kozaki S. The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a. FEBS Lett. 378:1996;253-257.
93. Nishiki T., Tokuyama Y., Kamata Y., Nemoto Y., Yoshida A., Sekiguchi M., Takahashi M., Kozaki S. Binding of botulinum type B neurotoxin to Chinese hamster ovary cells transfected with rat synaptotagmin II cDNA. Neurosci. Lett. 208:1996;105-108.
94. O'Sullivan G.A., Mohammed N., Foran P.G., Lawrence G.W., Oliver Dolly J.O. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues. J. Biol. Chem. 274:1999;36897-36904.
95. Osen Sand A., Staple J.K., Naldi E., Schiavo G., Rossetto O., Petitpierre S., Malgaroli A., Montecucco C., Catsicas S. Common and distinct fusion proteins in axonal growth and transmitter release. J. Comp. Neurol. 367:1996;222-234.
96. Parton R.G., Ockleford C.D., Critchley D.R. A study of the mechanism of internalisation of tetanus toxin by primary mouse spinal cord cultures. J. Neurochem. 49:1987;1057-1068.
97. Parton R.G., Ockleford C.D., Critchley D.R. Tetanus toxin binding to mouse spinal cord cells: an evaluation of the role of gangliosides in toxin internalization. Brain Res. 475:1988;118-127.
98. Pellizzari R., Rossetto O., Lozzi L., Giovedi S., Johnson E., Shone C.C., Montecucco C. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins. J. Biol. Chem. 271:1996;20353-20358.
99. Pellizzari R., Mason S., Shone C.C., Montecucco C. The interaction of synaptic vesicle-associated membrane protein/synaptobrevin with botulinum neurotoxins D and F. FEBS Lett. 409:1997;339-342.
100. Pierce E.J., Davison M.D., Parton R.G., Habig W.H., Critchley D.R. Characterization of tetanus toxin binding to rat brain membranes. Evidence for a high-affinity proteinase-sensitive receptor. Biochem. J. 236:1986;845-852.
101. Pitzurra L., Rossetto O., Chimienti A.R., Blasi E., Bistoni F. Tetanus toxin-sensitive VAMP-related proteins are present in murine macrophages. Cell. Immun. 169:1996;113-116.
102. Poirier M.A., Xiao W., Macosko J.C., Chan C., Shin Y.K., Bennett M.K. The synaptic SNARE complex is a parallel four-stranded helical bundle. Nat. Struct. Biol. 5:1998;765-769.
103. Ponomarev A.W. Zur Frage der Pathogenese des Tetanus und des Fortbewegungsmechanismus des Tetanustoxin entlang der Nerven. Z. Ges. Exp. Med. 61:1928;93-106.
104. Raciborska D.A., Trimble W.S., Charlton M.P. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction. Eur. J. Neurosci. 10:1998;2617-2628.
105. Raciborska D.A., Charlton M.P. Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning. Can. J. Physiol. Pharmacol. 77:1999;679-688.
106. Rappuoli R., Montecucco C. Protein Toxins and their Use in Cell Biology. 1997;Oxford University Press, Oxford.
107. Rauch G., Gambale F., Montal M. Tetanus toxin channel in phosphatidylserine planar bilayers: conductance states and pH dependence. Eur. J. Biochem. 18:1990;79-83.
108. Rawlings N.D., Barrett A.J. Families of aspartic peptidases, and those of unknown catalytic mechanism. Methods Enzymol. 248:1995;105-120.
109. Roa M., Boquet P. Interaction of tetanus toxin with lipid vesicles at low pH. Protection of specific polypeptides against proteolysis. J. Biol. Chem. 260:1985;6827-6835.
110. Rossetto O., Schiavo G., Montecucco C., Poulain B., Deloye F., Lozzi L., Shone C.C. SNARE motif and neurotoxins. Nature. 372:1994;415-416.
111. Schantz E.J., Johnson E.A. Botulinum toxin: the story of its development for the treatment of human disease. Perspect. Biol. Med. 40:1997;317-327.
112. Schiavo G., Papini E., Genna G., Montecucco C. An intact interchain disulfide bond is required for the neurotoxicity of tetanus toxin. Infect. Immun. 58:1990;4136-4141.
113. Schiavo G., Ferrari G., Rossetto O., Montecucco C. Tetanus toxin receptor. Specific cross-linking of tetanus toxin to a protein of NGF-differentiated PC12 cells. FEBS Lett. 290:1991;227-230.
114. Schiavo G., Demel R., Montecucco C. On the role of polysialoglycosphingolipids as tetanus toxin receptor. A study with lipid monolayers. Eur. J. Biochem. 199:1991;705-711.
115. Schiavo G., Poulain B., Rossetto O., Benfenati F., Tauc L., Montecucco C. Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc. EMBO J. 11:1992;3577-3583.
116. Schiavo G., Rossetto O., Santucci A., Dasgupta B.R., Montecucco C. Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 267:1992;23479-23483.
117. Schiavo G., Benfenati F., Poulain B., Rossetto O., Polverino de Laureto P., Dasgupta B.R., Montecucco C. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature. 359:1992;832-835.
118. Schiavo G., Rossetto O., Catsicas S., Polverino de Laureto P., DasGupta B.R., Benfenati F., Montecucco C. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A. D, and E. J. Biol. Chem. 268:1993;23784-23787.
119. Schiavo G., Santucci A., Dasgupta B.R., Mehta P.P., Jontes J., Benfenati F., Wilson M.C., Montecucco C. Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett. 335:1993;99-103.
120. Schiavo G., Shone C.C., Rossetto O., Alexander F.C., Montecucco C. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin. J. Biol. Chem. 268:1993;11516-11519.
121. Schiavo G., Malizio C., Trimble W.S., Polverino de Laureto P., Milan G., Sugiyama H., Johnson E.A., Montecucco C. Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J. Biol. Chem. 269:1994;20213-20216.
122. Schiavo G., Montecucco C. Tetanus and botulism neurotoxins: isolation and assay. Methods Enzymol. 248:1995;643-652.
123. Schiavo G., Shone C.C., Bennett M.K., Scheller R.H., Montecucco C. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins. J. Biol. Chem. 270:1995;10566-10570.
124. Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80:2000;717-766.
125. Schmid M.F., Robinson J.P., dasgupta B.R. Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles. Nature. 364:1993;827-830.
126. Schwab M.E., Suda K., Thoenen H. Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J. Cell. Biol. 82:1979;798-810.
127. Scott A.B. Clostridial neurotoxins as therapeutic agents. Simpson L.L. Botulinum Neurotoxin and Tetanus Toxin. 1989;399-412 Academic Press, San Diego.
128. Sellin L.C., Thesleff S., Dasgupta B.R. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction. Acta Physiol. Scan. 119:1983;127-133.
129. 2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur. J. Biochem. 167:1987;175-180.
130. Shone C.C., Quinn C.P., Wait R., Hallis B., Fooks S.G., Hambleton P. Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin. Eur. J. Biochem. 217:1993;965-971.
131. Shone C.C., Roberts A.K. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Eur. J. Biochem. 225:1994;263-270.
132. Shumaker H.B., Lamont A., Firor W.M. The reaction of 'tetanus sensitive' and 'tetanus resistant' animals to the injection of tetanal toxin into the spinal cord. J. Immunol. 37:1939;425-433.
133. Simpson L.L. The interaction between aminoquinolines and presynaptically acting neurotoxins. J. Pharmacol. Exp. Ther. 222:1982;43-48.
134. Simpson L.L. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J. Pharmacol. Exp. Ther. 225:1983;546-552.
135. Simpson L.L. Botulinum Neurotoxin and Tetanus Toxin. 1993;Academic Press, San Diego.
136. Simpson L.L., Coffield J.L., Bakry N. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J. Pharmacol. Exp. Ther. 269:1994;256-269.
137. Sloop R.R., Cole B.A., Escutin R.O. Human response to botulinum toxin injection: type B compared with type A. Neurology. 49:1997;189-194.
138. Smith L.D., Sugiyama H. Botulism: The Organism, Its Toxins, The Disease. 1988;C.C. Thomas Publishers, Springfield, IL.
139. Staub G.C., Walton K.M., Schnaar R.L., Nichols T., Baichwal R., Sandberg K., Rogers T.B. Characterization of the binding and internalization of tetanus toxin in a neuroblastoma hybrid cell line. J. Neurosci. 6:1986;1443-1451.
140. Sutton R.B., Fasshauer D., Jahn R., Brunger A.T. Crystal-structure of a SNARE complex involved in synaptic exocytosis at 2.4 Å resolution. Nature. 395:1998;347-353.
141. Swaminathan S., Eswaramoorthy S. Crystal structure of botulinum neurotoxin B. Proc. Int. Conference on Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando :1999;28.
142. Sweeney S.T., Broadie K., Keane J., Niemann H., O'Kane C.J. Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron. 14:1995;341-351.
143. Takano K., Kirchner F., Gremmelt A., Matsuda M., Ozutsumi N., Sugimoto N. Blocking effects of tetanus toxin and its fragment [A-B] on the excitatory and inhibitory synapses of the spinal motoneurons of the cat. Toxicon. 27:1989;385-392.
144. Tizzoni G., Cattani G. Untersuchungen uber das Tetanusgift. Arc. Exp. Pathol. Pharmakol. 27:1890;432-450.
145. Tizzoni G., Cattani G. Uber das Tetanusgift. Zentralbl Bakt. 8:1890;69-73.
146. Tonello F., Pellizzar R., Pasqualeto S., Graudi G., Peggion E., Montecucco C. Recombinant and truncated tetanus neurotoxin light chain: cloning, expansion, purification and proteolytic activity. Protein. Exp. Purif. 15:1999;221-227.
147. Tonello F., Schiavo G., Montecucco C. Metal substitution of tetanus neurotoxin. Biochem. J. 322:1997;507-510.
148. Umland T.C., Wingert L.M., Swaminathan S., Furey W.F., Schmidt J.J., Sax M. Structure of the receptor binding fragment Hc of tetanus toxin. Nature Struct. Biol. 4:1997;788-792.
149. van Ermengem E. Uber ein neuenanaeroben Bacillus und seine Beziehungen zum Botulismus. Ztschr. Hyg. Infektkr. 26:1897;1-56.
150. van Heyningen W.E. Tetanus. Sci. Am. 218:1968;69-77.
151. Vaidyanathan V.V., Yoshino K., Jahnz M., Dorries C., Bade S., Nauenburg S., Niemann H. Proteolysis of SNAP-25 isoforms by botulinum neurotoxins type A, C and E: domains of amino-acid residues controlling the formation of enzyme-substrate complexes and cleavage. J. Neurochem. 72:1999;327-337.
152. Verderio C., Coco S., Rossetto O., Montecucco C., Matteoli M. Internalization and proteolytic action of botulinum toxins in CNS neurons and astrocytes. J. Neurochem. 73:1999;372-379.
153. Washbourne P., Pellizzari R., Baldini G., Wilson M.C., Montecucco C. Botulinum neurotoxin type-A and type-E require the SNARE motif in SNAP-25 for proteolysis. FEBS Lett. 418:1997;1-5.
154. Weber T., Zemelman B.V., McNew J.A., Westermann B., Gmachl M.J., Parlati F., Sllner T.H., Rothman J.E. SNAREpins: minimal machinery for membrane fusion. Cell. 92:1998;759-772.
155. Wei S.H., Xu T., Ashery U., Kollewe A., Matti U., Antonin W., Rettig J., Neher E. Exocytotic mechanism studied by truncated and zero layer mutants of the C-terminus of SNAP-25. EMBO J. 19:2000;1279-1289.
156. Weller U., Taylor C.F., Habermann E. Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon. 24:1986;1055-1063.
157. 125I -tetanus toxin. Naunyn Schmiedeberg's Arch. Pharmacol. 276:1973;375-386.
158. Wellhoner H.H., Neville D.M. Jr. Tetanus toxin binds with high affinity to neuroblastoma × glioma hybrid cells NG 108 15 and impairs their stimulated acetylcholine release. J. Biol. Chem. 262:1987;17374-17378.
159. Wellhoner H.H. Tetanus and botulinum neurotoxins. Herchen H., Hucho F. Handbook of Experimental Pharmacology. vol. 102:1992;357-417 Springer-Verlag, Berlin.
160. Witcome M., Rossetto O., Montecucco C., Shone C.C. Substrate residues N-terminal to the cleavage site of botulinum type B neurotoxin play a role in determining the specificity of its endopeptidase activity. FEBS Lett. 386:1996;133-136.
161. Williamson L.C., Neale E.A. Bafilomycin A1 inhibits the action of tetanus toxin in spinal cord neurons in cell culture. J. Neurochem. 63:1994;2342-2345.
162. Williamson L.C., Halpern J.L., Montecucco C., Brown J.E., Neale E.A. Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kDa. J. Biol. Chem. 271:1996;7694-7699.
163. Xu T., Binz T., Niemann H., Neher E. Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nature Neurosci. 1:1998;192-200.
164. Xu T., Rammner B., Margittai M., Artalejo A.R., Neher E., Jahn R. Inhibition of SNARE complex assembly differentially affects kinetic components of exocytosis. Cell. 99:1999;713-722.
165. Yamasaki S., Baumeister A., Binz T., Blasi J., Link E., Cornille F., Roques B., Fykse E.M., Sudhof T.C., Jahn R., Niemann H. Cleavage of members of the synaptobrevin/VAMP family by types D and F botulinal neurotoxins and tetanus toxin. J. Biol. Chem. 269:1994;12764-12772.
166. Yamasaki S., Binz T., Hayashi T., Szabo E., Yamasaki N., Eklund M., Jahn R., Niemann H. Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2. Biochem. Biophys. Res. Commun. 200:1994;829-835.
167. Yamasaki S., Hu Y., Binz T., Kalkuhl A., Kurazono H., Tamura T., Jahn R., Kandel E., Niemann H. Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc. Natl. Acad. Sci. USA. 91:1994;4688-4692.
168. Yavin E., Nathan A. Tetanus toxin receptors on nerve cells contain a trypsin-sensitive component. Eur. J. Biochem. 154:1986;403-407.